Akari Therapeutics Plc
AKTXNasdaq
$11.01
↓ -4.3%Jul 17 close · end-of-day
Price
1Y↓ -75.2%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$1.3T
Enterprise Value
$1.3T
P/E
—
P/S
—
P/B
90925.9
EV/EBITDA
—
PEG
—
FCF Yield
—
Dividend Yield
—
Revenue (TTM)
—
Net Income (TTM)
-$28.0M
Free Cash Flow (TTM)
—
Gross Margin
—
Operating Margin
—
Net Margin
—
ROE
-195.0%
ROIC
-200.7%
Debt / Equity
—
Net Cash
$2.8M
Return 1Y
-75.6%
Company profile
Management & directors
- Farag Kameel D.Interim CFO
- Gaslightwala AbizerPresident & CEO
Roles derived from SEC Form 4 filings.
Earnings
AKTX Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue——
Diluted EPS$0.00—
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | — | — | $607,681.00 | $367,877.00 | — | — |
| Gross profit | — | — | — | — | — | — |
| Operating income | -$18.0M | -$17.2M | -$23.1M | -$16.8M | -$21.6M | -$17.3M |
| Net income | -$17.1M | -$17.4M | -$17.7M | -$10.0M | -$19.8M | -$17.3M |
| Diluted EPS | -$0.01 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating cash flow | -$17.0M | -$18.8M | -$21.5M | -$16.4M | -$12.6M | -$10.6M |
| Free cash flow | — | — | -$21.6M | -$16.4M | — | — |
| Gross margin | — | — | — | — | — | — |
| Operating margin | — | — | -3799.4% | -4568.4% | — | — |
| Net margin | — | — | -2920.6% | -2720.5% | — | — |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0.00 | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | -$7.4M | -$2.9M | -$5.3M | -$3.5M | -$3.1M | -$7.4M | -$3.2M | -$15.8M |
| Net income | -$7.6M | -$2.9M | -$3.8M | -$3.7M | -$1.9M | -$6.4M | -$5.3M | -$14.5M |
| Diluted EPS | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating cash flow | -$4.9M | -$1.5M | -$2.1M | -$2.1M | -$3.3M | -$2.1M | -$3.0M | -$2.5M |
| Free cash flow | — | — | — | — | — | — | — | — |
| Gross margin | — | — | — | — | — | — | — | — |
| Operating margin | — | — | — | — | — | — | — | — |
| Net margin | — | — | — | — | — | — | — | — |
Company news
Coming soonHeadlines for AKTX will appear here once the news feed is connected.
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-07-07 | Patel Samir Rashmikant | Option exercise | 1,209 | $8.00 | $9,672.00 | filing |
| 2026-07-07 | Patel Samir Rashmikant | Option exercise | 15,466 | $0.00 | $6.19 | filing |
| 2026-07-07 | Patel Samir Rashmikant | Option exercise | 5,799 | $0.00 | $2.32 | filing |
| 2026-06-24 | Farag Kameel D.· Interim CFO | Award | 7,353 | $3.74 | $27,500.22 | filing |
| 2026-06-24 | Farag Kameel D.· Interim CFO | Award | 1,395 | $9.32 | $13,001.40 | filing |
| 2026-06-24 | Farag Kameel D.· Interim CFO | Award | 3,725 | $3.49 | $13,000.25 | filing |
| 2026-06-24 | Farag Kameel D.· Interim CFO | Award | 1,000 | $13.00 | $13,000.00 | filing |
| 2026-06-24 | Farag Kameel D.· Interim CFO | Award | 2,539 | $5.12 | $12,999.68 | filing |
| 2026-06-24 | Farag Kameel D.· Interim CFO | Award | 1,570 | $8.28 | $12,999.60 | filing |
| 2026-06-24 | Farag Kameel D.· Interim CFO | Award | 1,248 | $10.02 | $12,504.96 | filing |
| 2025-11-01 | Farag Kameel D.· Interim CFO | Award | 32,000 | $0.75 | $24,000.00 | filing |
| 2025-11-01 | Farag Kameel D.· Interim CFO | Award | 26,619 | $0.75 | $19,964.25 | filing |
| 2025-10-22 | Farag Kameel D.· Interim CFO | Award | 6,277 | $0.74 | $4,644.98 | filing |
| 2025-08-25 | Gaslightwala Abizer· CEO | Buy | 3,000 | $0.90 | $2,700.00 | filing |
| 2025-08-22 | Gaslightwala Abizer· CEO | Buy | 8,000 | $0.93 | $7,440.00 | filing |
| 2025-08-21 | Gaslightwala Abizer· CEO | Buy | 10,000 | $0.94 | $9,400.00 | filing |
| 2025-06-24 | Gaslightwala Abizer· President & CEO | Buy | 5,203 | $1.16 | $6,035.48 | filing |
| 2025-06-23 | Gaslightwala Abizer· President & CEO | Buy | 943 | $1.15 | $1,084.45 | filing |
| 2025-06-20 | Gaslightwala Abizer· President & CEO | Buy | 10,000 | $1.20 | $12,000.00 | filing |
| 2025-06-17 | Gaslightwala Abizer· President & CEO | Buy | 15,000 | $1.20 | $18,000.00 | filing |
Latest 20 transactions.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.